ES2133772T3 - Inmunoensayo para la homocisteina. - Google Patents

Inmunoensayo para la homocisteina.

Info

Publication number
ES2133772T3
ES2133772T3 ES95920371T ES95920371T ES2133772T3 ES 2133772 T3 ES2133772 T3 ES 2133772T3 ES 95920371 T ES95920371 T ES 95920371T ES 95920371 T ES95920371 T ES 95920371T ES 2133772 T3 ES2133772 T3 ES 2133772T3
Authority
ES
Spain
Prior art keywords
analyte
homocysteine
immunologically
antibodies
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920371T
Other languages
English (en)
Inventor
Atta Reuel B Van
Thomas C Goodman
Edwin F Ullman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2133772T3 publication Critical patent/ES2133772T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON METODOS PARA DETECTAR UN COMPUESTO EN PRESENCIA DE UN HOMOLOGO QUE ESTA INMUNOLOGICAMENTE RELACIONADO CON EL ANALITO. LA INVENCION PARTICULARMENTE ADECUADA PARA LA DETECCION DE HOMOCISTEINA EN PRESENCIA DE CISTEINA. LOS METODOS DE ESTA INVENCION LLEVAN CONSIGO LA MODIFICACION DE AMBOS EL ANALITO Y EL HOMOLOGO PARA INCREMENTAR SU INMUNOGENICIDAD Y FACILITAR EL RECONOCIMIENTO DE ANTICUERPOS. DE MANERA MAS IMPORTANTE, SE HACE ESTA MODIFICACION PARA HACER QUE ESTOS COMPUESTOS SEAN DISTINTOS INMUNOLOGICAMENTE. DESPUES, SE PREPARAN LOS ANTICUERPOS DE LOS COMPUESTOS DISTINTOS INMUNOLOGICAMENTE. UN PROTOCOLO DE ENSAYO CONSISTE EN LA MODIFICACION QUIMICA DEL ANALITO Y EL HOMOLOGO Y, DESPUES, LA DETECCION INMUNOQUIMICA DEL ANALITO MODIFICADO POR MEDIO DE LOS ANTICUERPOS MENCIONADOS ANTERIORMENTE.
ES95920371T 1994-04-28 1995-04-27 Inmunoensayo para la homocisteina. Expired - Lifetime ES2133772T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/234,456 US5478729A (en) 1994-04-28 1994-04-28 Immunoassay for homocysteine

Publications (1)

Publication Number Publication Date
ES2133772T3 true ES2133772T3 (es) 1999-09-16

Family

ID=22881471

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920371T Expired - Lifetime ES2133772T3 (es) 1994-04-28 1995-04-27 Inmunoensayo para la homocisteina.

Country Status (8)

Country Link
US (1) US5478729A (es)
EP (1) EP0757794B1 (es)
JP (1) JP3422795B2 (es)
AU (1) AU2584495A (es)
CA (1) CA2188752C (es)
DE (1) DE69504191T2 (es)
ES (1) ES2133772T3 (es)
WO (1) WO1995030151A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063581A (en) * 1992-01-22 2000-05-16 Axis-Shield Asa Immunoassay for homocysteine
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
AU7031598A (en) * 1997-03-06 1998-09-22 Evotec Biosystems Gmbh Method for specifically marking a protein
DE19713088C1 (de) 1997-03-27 1998-11-26 Reiner Dr Probst Verfahren und Blutabnahmegefäß zur Aufbereitung von Blutproben für die Homocystein- und/oder Folatbestimmung
US6020206A (en) * 1997-06-23 2000-02-01 Nexstar Pharmaceuticals, Inc. Homocysteine assay
US5985540A (en) * 1997-07-24 1999-11-16 Anticancer, Inc. High specificity homocysteine assays for biological samples
US6066467A (en) * 1997-07-24 2000-05-23 Anticancer, Inc. High specificity homocysteine assays for biological samples
US6140102A (en) * 1997-07-24 2000-10-31 Anticancer, Inc. High specificity homocysteinases and genes therefor
US6468762B1 (en) 1997-07-24 2002-10-22 Anticancer, Inc. High specificity homocysteinases
US6589751B2 (en) * 1997-11-04 2003-07-08 Mcw Research Foundation Immonological detection of the homocystamide adduct and a thiolactone immunoassay for endogeneous homocysteine
US5885767A (en) * 1998-05-22 1999-03-23 Biocatalytics, Inc. Methods and compositions for quantitating L-homocysteine and/or l-methionine in a solution
WO2000000821A1 (en) 1998-06-29 2000-01-06 Ullman Edwin F Assay for homocysteine
US6174696B1 (en) 1999-11-12 2001-01-16 Genzyme Corporation Method for the determination of homocysteine
CA2361077C (en) 1999-02-01 2010-10-19 Anticancer, Inc. Homogeneous enzymatic assay for vitamin b6 and improvements in h2s detection
US7105310B1 (en) * 2000-07-19 2006-09-12 California Institute Of Technology Detection of biomolecules by sensitizer-linked substrates
WO2001006260A1 (en) * 1999-07-19 2001-01-25 California Institute Of Technology Detection of biomolecules by sensitizer-linked substrates
US6783947B1 (en) * 1999-09-09 2004-08-31 Dade Behring Marburg Gmbh Protecting groups for biological labeling
ATE377655T1 (de) 2000-06-30 2007-11-15 Alfresa Pharma Corp Verfahren zum messen von gesamt-homocystein
CA2422856C (en) * 2000-09-25 2012-02-07 Abbott Laboratories Methods and kits for decreasing interferences of assay samples containing plasma or serum in specific binding assays by using a large polycation
AU2002318396A1 (en) * 2001-06-21 2003-01-08 The Cleveland Clinic Foundation Homocysteinylated transthyretin
US20050019937A1 (en) * 2002-11-29 2005-01-27 Industrial Technology Research Institute Assay and kit for homocysteine
JP2006149203A (ja) * 2003-02-19 2006-06-15 Alfresa Pharma Corp ホモシステインの測定方法
US9201075B2 (en) 2004-04-30 2015-12-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Colorimetric and fluorometric determination of homocysteine and cysteine
US20070259376A1 (en) * 2005-12-22 2007-11-08 Toru Yoshimura Homocysteine immunoassay
JP2007170992A (ja) * 2005-12-22 2007-07-05 Abbott Japan Co Ltd ホモシステインの免疫学的測定方法
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US20160289728A1 (en) * 2013-11-21 2016-10-06 The University Of Tokyo Method for detecting fluorescence or absorbance, method for suppressing background, method for measuring adp, method for measuring activity of adp-synthesizing enzyme, and method for measuring activity of glucosyltransferase
JP6811581B2 (ja) * 2016-10-25 2021-01-13 福井県 人血検査方法及び人血検査用キット
CN114181909B (zh) * 2021-11-25 2023-06-06 深圳市圳康科技有限公司 一种杂交瘤细胞株及其单克隆抗体与试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940658A (en) * 1986-11-20 1990-07-10 University Patents, Inc. Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency
US5374560A (en) * 1989-04-03 1994-12-20 The University Of Colorado, Inc. Method for screening and distinguishing between cobalamin and folic acid deficiency based on assay for cystathionine and 2-methylcitric acid
US4868132A (en) * 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US4952336A (en) * 1987-02-03 1990-08-28 Abbott Laboratories Fluorescence polymerization immunoassay for amphetamine/methamphetamine
CA1335880C (en) * 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US4978632A (en) * 1988-12-15 1990-12-18 Kallestad Diagnostics, Inc. Method of pre-treating samples in peroxidase-catalyzed enzyme assays
GB8924112D0 (en) * 1989-10-26 1989-12-13 Univ Southampton Assay pretreatment
WO1993012424A1 (en) * 1991-12-13 1993-06-24 Abbott Laboratories Determination of tricyclic antidepressant drugs in the presence of interfering substances
WO1993015220A1 (en) * 1992-01-22 1993-08-05 Axis Biochemicals As Homocysteine assay
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents

Also Published As

Publication number Publication date
DE69504191D1 (de) 1998-09-24
JP3422795B2 (ja) 2003-06-30
AU2584495A (en) 1995-11-29
EP0757794A1 (en) 1997-02-12
US5478729A (en) 1995-12-26
CA2188752C (en) 2002-08-06
DE69504191T2 (de) 1999-02-11
CA2188752A1 (en) 1995-11-09
WO1995030151A1 (en) 1995-11-09
EP0757794B1 (en) 1998-08-19
JPH09512634A (ja) 1997-12-16

Similar Documents

Publication Publication Date Title
ES2133772T3 (es) Inmunoensayo para la homocisteina.
NO169844C (no) Htlv-iii (env)-peptider
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
SE7900662L (sv) Forfarande och reagens for immunoanalys
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
ATE161289T1 (de) Repamycinbestimmung
DE60232248D1 (de) Schwangerschaftsnachweisverfahren
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ES2182825T3 (es) Metodo para disociar un inmunocomplejo e inmunoensayo que lo utiliza.
GB8915512D0 (en) Silver enhanced gold-labelled immuno assay method
DE3854553D1 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
PT902286E (pt) Imunoensaio utilizando duas incubacoes com antigenios marcados
Hillyer et al. Use of immunologic techniques to detect chemotherapeutic success in infections with Fasciola hepatica II. The enzyme linked immunosorbent assay in infected rats and rabbits
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ES2130703T3 (es) Conjugados de benzodiazepinas y proteinas y su utilizacion para la determinacion inmunologica de benzodiazepinas.
ES2056919T3 (es) Anticuerpo monoclonal especifico para la fosfolipasa a2 pancreatica humana.
McArthur et al. A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945.
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ES2126608T3 (es) Procedimiento para la determinacion de antigenos o anticuerpos en presencia de un inmunocomplejo.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 757794

Country of ref document: ES